Will the U.S. Keep Buying Medicine for ‘Black Swan’ Attacks?

An analytical chemist in Pennsylvania conducts testing for a developmental drug in 2003. Lawmakers are set to consider whether to continue funding a multibillion-dollar program to develop drug treatments for relatively unlikely unconventional attacks.
National Journal
Diane Barnes
Add to Briefcase
Diane Barnes
June 26, 2014, 11 a.m.

Con­gress will weigh this year wheth­er to con­tin­ue spend­ing bil­lions of dol­lars on an­ti­dotes for at­tacks seen as re­l­at­ively un­likely, but po­ten­tially dev­ast­at­ing.

Law­makers helped to es­tab­lish Pro­ject Bioshield in 2004 to in­centiv­ize oth­er­wise un­prof­it­able work on treat­ments for exot­ic pos­sible ter­ror­ism tools, such as an­thrax and botulin­um tox­in. In com­ing months, though, the dec­ade-old ini­ti­at­ive could face un­pre­ced­en­ted scru­tiny of its fund­ing, in part due to a dearth of chem­ic­al, bio­lo­gic­al, ra­di­olo­gic­al and nuc­le­ar at­tacks in the United States since its launch, says a newly pub­lished Con­gres­sion­al Re­search Ser­vice re­port.

“Con­gres­sion­al poli­cy­makers could de­cide not to fund Pro­ject Bioshield,” ana­lyst Frank Got­tron said in the as­sess­ment. “Giv­en the con­tin­ued ab­sence of any [WMD] ter­ror­ist at­tacks in the United States since 2001, [they] could deem that the per­ceived risk of an at­tack no longer jus­ti­fies [the] con­tin­ued in­vest­ment.”

“Al­tern­at­ively, poli­cy­makers could deem oth­er, more con­ven­tion­al, coun­ter­meas­ure pro­cure­ment meth­ods suf­fi­cient or more ef­fi­cient than Pro­ject Bioshield and re­dir­ect fund­ing to those pro­grams,” Got­tron wrote.

Con­gress guar­an­teed Pro­ject Bioshield a steady $560 mil­lion in an­nu­al fund­ing for its first dec­ade by set­ting aside bil­lions in ad­vance. The Health and Hu­man Ser­vices De­part­ment set aside more than half of the pro­gram’s 10-year, $5.6 bil­lion “spe­cial re­serve fund” to ac­quire treat­ments for symp­toms of a wide vari­ety of po­ten­tial un­con­ven­tion­al as­saults. Of the $3.3 bil­lion ear­marked for WMD threats, about one-third went to­ward small­pox drugs, in case the long-erad­ic­ated vir­us is ever re­built or re­leased from a rare labor­at­ory stock­pile.

Law­makers last year au­thor­ized the pro­gram to con­tin­ue re­ceiv­ing the same amount of money through fisc­al 2018. Rather than main­tain­ing its spe­cial re­serve fund, though, they left fund­ing levels to be de­term­ined through the an­nu­al ap­pro­pri­ations pro­cess.

The pro­gram re­ceived $255 mil­lion in fisc­al 2014 ap­pro­pri­ations, and the Obama ad­min­is­tra­tion is seek­ing $415 mil­lion in the up­com­ing budget cycle.

“The switch to an­nu­al ap­pro­pri­ations may com­plic­ate [the Health and Hu­man Ser­vices De­part­ment’s] long-term coun­ter­meas­ure de­vel­op­ment and ac­quis­i­tion plan­ning,” Got­tron wrote. “Some de­velopers con­tend that an ad­vance ap­pro­pri­ation helps com­pany man­age­ment more fa­vor­ably con­sider a po­ten­tial coun­ter­meas­ure when weigh­ing in­tern­al in­vest­ment op­por­tun­ity costs.”

Law­makers may ul­ti­mately re­in­state an ap­proach sim­il­ar to the 10-year re­serve fund, the ana­lyst ad­ded.

“De­velopers might prefer ad­vance ap­pro­pri­ations for as long a peri­od as pos­sible,” he wrote. “However, provid­ing an ad­vance ap­pro­pri­ation dur­ing the cur­rent fisc­al en­vir­on­ment may prove more dif­fi­cult than in 2003.”

What We're Following See More »
TRUMP’S ATTORNEY WAS SET TO TESTIFY ON WEDNESDAY
Senate Intel Postpones Testimony by Cohen
16 hours ago
THE LATEST
AMENDMENT WOULD HAVE PREVENTED CONSIDERATION
Senate Rejects Effort to Nix SALT Tax Changes
1 days ago
THE LATEST

"Senate Democrats on Thursday failed in their first attempt to save the state and local tax deduction, which helps many residents of California and other high-cost states reduce their federal income tax bills. The Republican-controlled Senate voted 52-47 to reject an amendment that would have prevented the Senate from considering any bill that repeals or limits the deduction as part of a planned tax overhaul."

Source:
INTERVIEWED BY COMMITTEE STAFF
Lewandowski Meets with Senate Intelligence Committee
1 days ago
THE LATEST

"President Donald Trump's former campaign manager Corey Lewandowski appeared on Capitol Hill for a closed-door interview with the Senate intelligence committee Wednesday, according to a source familiar with the matter. Lewandowski is the latest senior official in Trump's orbit who has met with the committee as part of its investigation into Russian election meddling and possible collusion with the Trump campaign."

Source:
FISHING EXPEDITION
Some Members Seek to Wrap Up Russia Investigations by Year’s End
2 days ago
THE LATEST

"A growing number of key Republicans are sending this message to the leaders of the congressional committees investigating potential Trump campaign collusion with the Russians: Wrap it up soon. In the House and Senate, several Republicans who sit on key committees are starting to grumble that the investigations have spanned the better part of the past nine months, contending that the Democratic push to extend the investigation well into next year could amount to a fishing expedition."

Source:
WROTE LAW THAT WEAKENED OPIOID OVERSIGHT
Trump: Marino Withdrawing Nomination for Drug Czar
3 days ago
THE LATEST
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login